Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule while breastfeeding. We will also discuss about common side effects and warnings associated with Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule.

What is Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule used for?


JORNAY PM is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14)]. JORNAY PM is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. (1)

Can I continue breastfeeding if I am using Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule? How long does it stays in breast milk?

Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule safe for breastfeeding
As per our analysis Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule contains only one ingredient and that is Methylphenidate hydrochloride. We have analyzed Methylphenidate hydrochloride and it seems to be safe to use Methylphenidate hydrochloride while breastfeeding, that means usage of Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule shall be safe while breastfeeding. Below you can check more details of Methylphenidate hydrochloride usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule Breastfeeding Analsys


Methylphenidate hydrochloride while Breastfeeding

Safe

CAS Number: 113-45-1

The amount excreted to breast milk is so small that it is not detected in breast-fed infants. No adverse side-effects have been reported. Check-up for milk production since it may decrease Prolactin excretion on theoretical basis.

Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule Breastfeeding Analsys - 2


Methylphenidate hydrochloride while Breastfeeding

CAS Number: 113-45-1

In dosages prescribed for medical indications, limited evidence indicates that methylphenidate levels in milk are very low and not detectable in infant serum. The effects of methylphenidate in milk on the neurological development of the infant have not been well studied. If methylphenidate is required by the mother, it is not a reason to discontinue breastfeeding.[1] It is possible that large dosages of methylphenidate might interfere with milk production, especially in women whose lactation is not well established.

Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule and breastfeeding

What should I do if already breastfed my kid after using Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule and have used it then do not panic as Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule is mostly safe in breastfeeding and should not cause any harm to your baby.


My doctor has prescribed me Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule, what should I do?

Usage of Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule is safe for nursing mothers and baby, No worries.


If I am using Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Jornay Pm Extended-release | Methylphenidate Hydrochloride Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Aptensio Xr | (methylphenidate Hydrochloride) Capsule, Extended Release
Methylphenidate Hydrochloride Extended Release Tablet
Relexxii | Methylphenidate Hydrochloride Tablet, Extended Release
Methylphenidate Hydrochloride (cd) | Methylphenidate Hydrochloride Capsule, Extended Release
Methylphenidate Hcl | Methylphenidate Hydrochloride Solution
Methylphenidate Hydrochloride Extended-release | Methylphenidate Hydrochloride Tablet
Methylphenidate Hydrochloride Extended-release | Methylphenidate Hydrochloride Capsule